Skip to content

Effectiveness and safety of peritoneal dialysis treatment in patients with refractory congestive heart failure due to chronic cardio-renal syndrome

Effectiveness and safety of peritoneal dialysis treatment in patients with refractory congestive heart failure due to chronic cardio-renal syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015910
Enrollment
Unknown
Registered
2018-04-28
Start date
2007-01-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congestive heart failure

Interventions

two subgroups:peritoneal dialysis

Sponsors

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
29 Years to 84 Years

Inclusion criteria

Inclusion criteria: 1) aged above 18 years; 2) the extent of heart failure is assessed as stage III or IV based on the New York Heart Association (NYHA) functional classification; 3) heart function cannot be improved or sustained despite of maximal conservative treatment including large dose of diuretics; 4) recurrent hospitalization due to heart failure caused by volume overload (at least twice in the preceding 12 months).

Exclusion criteria

Exclusion criteria: 1) patients who suffered from an acute deterioration of heart and/or renal function; 2) estimated glomerular filtration rate (eGFR) calculated by Modification of Diet in Renal Disease (MDRD) equation is less than 10 mL/min/1.73m2; 3) ratio of serum urea to creatinine concentrations is less than or equal to 10.

Design outcomes

Primary

MeasureTime frame
body weight;blood pressure;residual renal function;hemoglobin;albumin;urine output;peritoneal ultrafiltation;dialysis dosage;NYHA class;B-type natriuretic peptide;left ventricular ejection fractions;

Countries

China

Contacts

Public ContactChunming Jiang

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School

guloujiang@sina.com+86 13815884488

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026